Furiex Pharmaceuticals, Inc. (FURX)
-NasdaqGS 36.93 
1.00(2.78%) Jun 18, 4:00PM EDT
| Prev Close: | 35.93 |
|---|
| Open: | 35.98 |
|---|
| Bid: | 13.00 x 200 |
|---|
| Ask: | 42.98 x 100 |
|---|
| 1y Target Est: | 52.00 |
|---|
| Beta: | 0.998 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 35.71 - 36.99 |
|---|
| 52wk Range: | 17.50 - 42.30 |
|---|
| Volume: | 97,569 |
|---|
| Avg Vol (3m): | 69,827 |
|---|
| Market Cap: | 373.51M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -2.42 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Furiex Pharmaceuticals Inc. Stock Downgraded (FURX)at TheStreet(Thu May 30)
- FURIEX PHARMACEUTICALS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security HoldersEDGAR Online(Wed May 29)
- FURIEX PHARMACEUTICALS, INC. FinancialsEDGAR Online Financials(Fri May 17)
- 5 Healthcare Stock Earnings Snapshotsat Wall St. Cheat Sheet(Sun May 12)
- Narrower-than-Expected Loss at ArQuleZacks(Thu May 9)
- FURIEX PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly ReportEDGAR Online(Thu May 9)
- Furiex Pharmaceuticals Management Discusses Q1 2013 Results - Earnings Call Transcriptat Seeking Alpha(Wed May 8)
- Furiex Pharmaceuticals Earnings: Here’s Why Investors are Not Happy Nowat Wall St. Cheat Sheet(Tue May 7)
- Furiex Reports First Quarter 2013 Financial ResultsBusiness Wire(Tue May 7)
- Furiex Pharmaceuticals: Here’s What Investors Need to Know Before Earningsat Wall St. Cheat Sheet(Tue May 7)
- FURIEX PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial StatementsEDGAR Online(Tue May 7)
- Q1 2013 Furiex Pharmaceuticals Inc Earnings Release - After Market CloseCCBN(Tue May 7)
- Narrower-than-Expected Loss at CadenceZacks(Mon May 6)
- Furiex Pharmaceuticals Announces First Quarter 2013 Earnings Release and Conference CallBusiness Wire(Tue Apr 9)
- FURIEX PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online(Tue Apr 9)
Key Statistics
| Forward P/E (1 yr): | 67.15 |
|---|
| P/S (ttm): | 4.71 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | -1.54 |
|---|
| Quarterly EPS Est
(Jun-13)
: | -1.28 |
|---|
| Mean Recommendation*: | 1.5 |
|---|
| PEG Ratio (5 yr expected): | -0.18 |
|---|
Business Summary
Furiex Pharmaceuticals, Inc., a drug development company, engages in the compound partnering business primarily in the United States. It collaborates with pharmaceutical and biotechnology companies to enhance the value of their drug candidates by ...
View More